Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эндорешерш, Инк.filedCriticalЭндорешерш, Инк.
Priority claimed from PCT/CA2008/001444external-prioritypatent/WO2009021323A1/en
Publication of UA100701C2publicationCriticalpatent/UA100701C2/ru
Tratamiento de enfermedad de alzheimer, perdida de cognición, perdida de memoria y demencia con precursores de esteroides sexuales en conbinación con moduladores selectivos del receptor de estrógenos.
Fulvestrant (Faslodex™, ICI 182,780) Is Active in Patients with Tamoxifen-Resistant Breast Cancer: Data from North American and European Randomized Trials